A detailed history of Baystate Wealth Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Baystate Wealth Management LLC holds 110 shares of RGEN stock, worth $15,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 110 -0.0%
Holding current value
$15,826
Previous $17,000 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$138.78 - $176.51 $9,020 - $11,473
65 Added 144.44%
110 $17,000
Q2 2023

Sep 21, 2023

BUY
$138.42 - $180.31 $6,228 - $8,113
45 New
45 $6,000
Q1 2021

Apr 21, 2021

BUY
$180.37 - $226.26 $7,755 - $9,729
43 Added 2150.0%
45 $9,000
Q4 2020

Jan 15, 2021

BUY
$148.08 - $206.57 $296 - $413
2 New
2 $0

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.